204 related articles for article (PubMed ID: 10653382)
1. Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.
Meyers BR; Papanicolaou GA; Sheiner P; Emre S; Miller C
Transplantation; 2000 Jan; 69(1):64-9. PubMed ID: 10653382
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid hepatotoxicity after orthotopic liver transplantation.
Schluger LK; Sheiner PA; Jonas M; Guarrera JV; Fiel IM; Meyers B; Berk PD
Mt Sinai J Med; 1996; 63(5-6):364-9. PubMed ID: 8898542
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Wada M
Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.
Aguado JM; Herrero JA; Gavaldá J; Torre-Cisneros J; Blanes M; Rufí G; Moreno A; Gurguí M; Hayek M; Lumbreras C; Cantarell C
Transplantation; 1997 May; 63(9):1278-86. PubMed ID: 9158022
[TBL] [Abstract][Full Text] [Related]
6. [Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability].
Wada M; Yoshiyama T; Ogata H; Ito K; Mizutani S; Sugita H
Kekkaku; 1999 Apr; 74(4):353-60. PubMed ID: 10355221
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens.
Shamaei M; Mirsaeidi M; Baghaei P; Mosaei H; Marjani M; Tabarsi P
Am J Ther; 2017; 24(2):e144-e149. PubMed ID: 26057141
[TBL] [Abstract][Full Text] [Related]
8. Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report.
Saigal S; Agarwal SR; Nandeesh HP; Sarin SK
J Gastroenterol Hepatol; 2001 Sep; 16(9):1028-32. PubMed ID: 11595068
[TBL] [Abstract][Full Text] [Related]
9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment.
Bartoletti M; Martelli G; Tedeschi S; Morelli M; Bertuzzo V; Tadolini M; Pianta P; Cristini F; Giannella M; Lewis RE; Pinna AD; Viale P
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054732
[TBL] [Abstract][Full Text] [Related]
11. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.
Ichai P; Saliba F; Antoun F; Azoulay D; Sebagh M; Antonini TM; Escaut L; Delvart V; Castaing D; Samuel D
Liver Transpl; 2010 Oct; 16(10):1136-46. PubMed ID: 20879012
[TBL] [Abstract][Full Text] [Related]
12. Standard therapy for tuberculosis 1985.
Snider DE; Cohn DL; Davidson PT; Hershfield ES; Smith MH; Sutton FD
Chest; 1985 Feb; 87(2 Suppl):117S-124S. PubMed ID: 3881230
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis in Egyptian kidney transplant recipients: study of clinical course and outcome.
el-Agroudy AE; Refaie AF; Moussa OM; Ghoneim MA
J Nephrol; 2003; 16(3):404-11. PubMed ID: 12832742
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis in heart transplant recipients.
Körner MM; Hirata N; Tenderich G; Minami K; Mannebach H; Kleesiek K; Körfer R
Chest; 1997 Feb; 111(2):365-9. PubMed ID: 9041983
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis in liver transplant patients.
Meyers BR; Halpern M; Sheiner P; Mendelson MH; Neibart E; Miller C
Transplantation; 1994 Aug; 58(3):301-6. PubMed ID: 8053051
[TBL] [Abstract][Full Text] [Related]
16. The high incidence of tuberculosis among renal transplant recipients in India.
Sakhuja V; Jha V; Varma PP; Joshi K; Chugh KS
Transplantation; 1996 Jan; 61(2):211-5. PubMed ID: 8600625
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
18. The management of anti-tuberculosis drug-induced hepatotoxicity.
Tahaoğlu K; Ataç G; Sevim T; Tärün T; Yazicioğlu O; Horzum G; Gemci I; Ongel A; Kapakli N; Aksoy E
Int J Tuberc Lung Dis; 2001 Jan; 5(1):65-9. PubMed ID: 11263519
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
[TBL] [Abstract][Full Text] [Related]
20. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
